Revolution Medicines Inc (NASDAQ: RVMD) is 102.68% higher on its value in year-to-date trading and has touched a low of $19.05 and a high of $62.40 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RVMD stock was last observed hovering at around $59.33 in the last trading session, with the day’s loss setting it -1.2%.
Currently trading at $58.13, the stock is 9.23% and 19.63% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.14 million and changing -2.02% at the moment leaves the stock 44.70% off its SMA200. RVMD registered 195.83% gain for a year compared to 6-month gain of 47.58%. The firm has a 50-day simple moving average (SMA 50) of $48.2776 and a 200-day simple moving average (SMA200) of $40.02425.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 18.66% loss in the last 1 month and extending the period to 3 months gives it a 33.57%, and is -2.17% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.76% over the week and 4.44% over the month.
Revolution Medicines Inc (RVMD) has around 378 employees, a market worth around $9.78B and $0.74M in sales. Profit margin for the company is -76423.32%. Distance from 52-week low is 205.14% and -6.84% from its 52-week high. The company has generated returns on investments over the last 12 months (-34.48%).
The EPS is expected to grow by 9.54% this year
350.0 institutions hold shares in Revolution Medicines Inc (RVMD), with institutional investors hold 104.89% of the company’s shares. The shares outstanding are 164.67M, and float is at 141.22M with Short Float at 12.85%. Institutions hold 102.65% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 14.38 million shares valued at $558.02 million. The investor’s holdings represent 0.0087 of the RVMD Shares outstanding. As of 2024-06-30, the second largest holder is WELLINGTON MANAGEMENT GROUP LLP with 13.66 million shares valued at $530.15 million to account for 0.0083 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 13.41 million shares representing 0.0081 and valued at over $520.39 million, while FARALLON CAPITAL MANAGEMENT LLC holds 0.0059 of the shares totaling 9.76 million with a market value of $378.7 million.
Revolution Medicines Inc (RVMD) Insider Activity
Revolution Medicines Inc disclosed in a document filed with the SEC on Nov 06 ’24 that Cislini Jeff (General Counsel) sold a total of 6,000 shares of the company’s common stock. The trade occurred on Nov 06 ’24 and was made at $60.00 per share for $0.36 million. Following the transaction, the insider now directly holds 45634.0 shares of the RVMD stock.
Still, SEC filings show that on Nov 06 ’24, JEFFREY TODD CISLINI (Officer) Proposed Sale 6,000 shares at an average price of $56.75 for $0.34 million. The insider now directly holds shares of Revolution Medicines Inc (RVMD).
